We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Magna (MGA) Develops Transmission for Ferrari SF90 Stradale
Read MoreHide Full Article
Magna International Inc. (MGA - Free Report) recently announced that, in collaboration with sports car-maker, Ferarri, it has developed an innovative, next-generation dual-clutch 8-speed transmission (DCT) for the Ferrari SF90 Stradale.
Magna’s DCT powertrain technology combines light-weight, fuel-efficient technologies with highly-advanced engineering and manufacturing processes, providing a route to energy-efficient, modern mobility.
Per Magna, the state-of-the-art DCT incorporates latest technologies, like the honeycomb housing structure, which is expected to reduce vehicles’ weight by roughly 10 kg and boost torque-to-weight performance. The DCT will also help cut CO2 emissions.
Further, the Ferrari SF90 Stradale transmission will improve efficiency, weight and packaging in additional vehicle segments through technology transfer, benefiting Magna’s full line of conventional and hybrid DCTs, over the long run.
Meanwhile, Magna is also expanding its business through joint ventures and hub openings while divesting the non-core units. In first-half 2019, the company inked a framework agreement for an electric vehicle manufacturing joint venture with an affiliate of BAIC. This August, it marked the opening of a $50-million electronics manufacturing facility in Michigan, which is expected to solidify its presence in Grand Blanc Township. Further, Magna is set to acquire Wipac Czech s.r.o., in a bid to expand its engineering capabilities globally.
In the past three months, shares of Magna have underperformed the industry it belongs to. Its shares have gained 3.4% compared with the industry’s rise of 5.5%.
For 2019, Magna projects consolidated revenues of $38.7-$39.8 billion, down from the previously estimated $38.9-$41.1 billion. The company anticipates adjusted EBIT margin of 6.3-6.5%, reflecting a decline from the prior guidance of 6.6-6.9%. Its free cash flow is estimated in the $1.9-2.1 billion band despite the reduction of the consolidated sales and margins projections for 2019.
Zacks Rank and Stocks to Consider
Currently, Magna carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Auto-Tires-Trucks sector include Weichai Power Co. , Spartan Motors, Inc. and SPX Corporation (SPXC - Free Report) . While Weichai Power flaunts a Zacks Rank #1 (Strong Buy), Spartan Motors and SPX carry a Zacks Rank of 2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Weichai Power has a projected earnings growth rate of 6.11% for the current year. Its shares have gained 75.7% over the past year.
Spartan Motors has an estimated earnings growth rate of 85.42% for the ongoing year. The company’s shares have surged 157.2% in a year’s time.
SPX has an expected earnings growth rate of 23.18% for 2019. The stock has appreciated 92.3% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Magna (MGA) Develops Transmission for Ferrari SF90 Stradale
Magna International Inc. (MGA - Free Report) recently announced that, in collaboration with sports car-maker, Ferarri, it has developed an innovative, next-generation dual-clutch 8-speed transmission (DCT) for the Ferrari SF90 Stradale.
Magna’s DCT powertrain technology combines light-weight, fuel-efficient technologies with highly-advanced engineering and manufacturing processes, providing a route to energy-efficient, modern mobility.
Per Magna, the state-of-the-art DCT incorporates latest technologies, like the honeycomb housing structure, which is expected to reduce vehicles’ weight by roughly 10 kg and boost torque-to-weight performance. The DCT will also help cut CO2 emissions.
Further, the Ferrari SF90 Stradale transmission will improve efficiency, weight and packaging in additional vehicle segments through technology transfer, benefiting Magna’s full line of conventional and hybrid DCTs, over the long run.
Meanwhile, Magna is also expanding its business through joint ventures and hub openings while divesting the non-core units. In first-half 2019, the company inked a framework agreement for an electric vehicle manufacturing joint venture with an affiliate of BAIC. This August, it marked the opening of a $50-million electronics manufacturing facility in Michigan, which is expected to solidify its presence in Grand Blanc Township. Further, Magna is set to acquire Wipac Czech s.r.o., in a bid to expand its engineering capabilities globally.
In the past three months, shares of Magna have underperformed the industry it belongs to. Its shares have gained 3.4% compared with the industry’s rise of 5.5%.
For 2019, Magna projects consolidated revenues of $38.7-$39.8 billion, down from the previously estimated $38.9-$41.1 billion. The company anticipates adjusted EBIT margin of 6.3-6.5%, reflecting a decline from the prior guidance of 6.6-6.9%. Its free cash flow is estimated in the $1.9-2.1 billion band despite the reduction of the consolidated sales and margins projections for 2019.
Zacks Rank and Stocks to Consider
Currently, Magna carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Auto-Tires-Trucks sector include Weichai Power Co. , Spartan Motors, Inc. and SPX Corporation (SPXC - Free Report) . While Weichai Power flaunts a Zacks Rank #1 (Strong Buy), Spartan Motors and SPX carry a Zacks Rank of 2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Weichai Power has a projected earnings growth rate of 6.11% for the current year. Its shares have gained 75.7% over the past year.
Spartan Motors has an estimated earnings growth rate of 85.42% for the ongoing year. The company’s shares have surged 157.2% in a year’s time.
SPX has an expected earnings growth rate of 23.18% for 2019. The stock has appreciated 92.3% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>